Loading...
XTSE
KPT
Market cap93mUSD
Jul 09, Last price  
13.20CAD
1D
0.46%
1Q
18.07%
Jan 2017
-15.76%
IPO
-23.92%
Name

KP Tissue Inc

Chart & Performance

D1W1MN
XTSE:KPT chart
P/E
15.57
P/S
EPS
0.85
Div Yield, %
5.45%
Shrs. gr., 5y
0.61%
Rev. gr., 5y
%
Revenues
0k
01,728,000-2,277,000-33,410,00067,000000000000
Net income
9m
+249.53%
-3,364-285,000-2,518,000-31,344,000-1,722,000-5,441,000-173,000-6,528,000-1,953,0001,239,000-10,249,000-4,937,0002,433,0008,504,000
CFO
0k
-100.00%
01,353,000-2,277,000-33,410,00067,000-2,772,000-369,000-6,913,000-2,441,0001,151,0006,617,0006,984,0006,974,0000
Dividend
Dec 31, 20250.18 CAD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Mississauga, Canada, and incorporated in 2012, KP Tissue Inc. plays a significant role in the disposable tissue market. Through its ownership interest in Kruger Products L.P., the company is involved in the manufacturing, distribution, marketing, and sale of a diverse range of tissue products across both Canada and the United States. Its operations are structured into two distinct segments: Consumer and Away-From-Home. The product portfolio includes essential items such as bathroom and facial tissues, paper towels, and napkins, in addition to manufacturing private label tissue solutions for other brands. These products are sold under well-known brand names like Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, and Metro. KP Tissue reaches its consumer base through conventional retail channels, including grocery stores, mass merchants, club stores, drugstores, convenience outlets, and online platforms. For commercial users, including those in property management, healthcare, food services, manufacturing, lodging industries, and public facilities, products are supplied via a network of distributors.
IPO date
Dec 12, 2012
Employees
2,700
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT